United States Biotechnology & Medical Research

Palisade Bio Inc (PALI)

Track

Over the past 90 days, Palisade Bio Inc. saw 10 insider transactions resulting in a net negative value of approximately $159,697. While Robert Baltera Jr. consistently purchased shares, significant sales were executed by CEO/CFO John David Finley and CMO Mitchell Lawrence. These activities follow a recent earnings report that missed EPS expectations by 14.5%.
Ticker: PALI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Palisade Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 9 Jul 2026
Value US$1,686,440.74 | Price 403.20 | Shares 58,901 (-48.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-10 2026-07-09 B Purchase
Baltera Robert Jr.
Non-Executive Director
58,901 -48.8%
403.20
US$1,686,441 		58,901 -48.8% 403.20 US$1,686,441
2026-07-10 2026-07-08 B Purchase
Baltera Robert Jr.
Non-Executive Director
59,619 -40.2%
406.30
US$3,706,298 		59,619 -40.2% 406.30 US$3,706,298
2026-07-08 2026-07-07 B Purchase
Baltera Robert Jr.
Non-Executive Director
32,890 +29.8%
10.14
US$4,863,275 		32,890 +29.8% 10.14 US$4,863,275
2026-07-08 2026-07-07 S Sale
1.4
Jones Mitchell Lawrence

Chief Medical Officer

Officer
51,880 -35.6%
2.05
US$106,536 		51,880 -35.6% 2.05 US$106,536
2026-07-08 2026-07-07 S Sale
1.7
Finley John David

CEO, CFO

Executive Director
146,798 -40.3%
2.07
US$303,343 		146,798 -40.3% 2.07 US$303,343
2026-07-07 2026-07-07 PrS Proposed sale
1.4
Jones Mitchell Lawrence

Officer

Officer
53,000
2.04
US$108,120 		53,000 2.04 US$108,120
2026-07-07 2026-07-07 PrS Proposed sale
1.7
Finley John David

Officer

Officer
146,798
2.07
US$303,343 		146,798 2.07 US$303,343
2026-07-08 2026-07-06 B Purchase
Baltera Robert Jr.
Non-Executive Director
20,000 +5.5%
2.05
US$41,040 		20,000 +5.5% 2.05 US$41,040
2026-07-06 2026-07-02 B Purchase
Baltera Robert Jr.
Non-Executive Director
10,000 +2.8%
1.98
US$19,800 		10,000 +2.8% 1.98 US$19,800
2026-07-06 2026-07-01 B Purchase
Baltera Robert Jr.
Non-Executive Director
20,000 +5.9%
1.98
US$39,600 		20,000 +5.9% 1.98 US$39,600
2026-02-13 2026-02-12 S Sale
1.4
Jones Mitchell Lawrence

Chief Medical Officer

Officer
1,989 -13.0%
1.75
US$3,481 		1,989 -13.0% 1.75 US$3,481
2026-02-13 2026-02-12 S Sale
1.7
Finley John David

CEO, CFO

Executive Director
3,896 -12.5%
1.75
US$6,818 		3,896 -12.5% 1.75 US$6,818
2026-01-21 2026-01-16 B Purchase
3.2
Williams Donald Allen
Non-Executive Director
5,000 +87.3%
1.67
US$8,356 		5,000 +87.3% 1.67 US$8,356
2026-01-13 2026-01-09 B Purchase
3.2
Williams Donald Allen
Non-Executive Director
5,000 +686.8%
1.88
US$9,400 		5,000 +686.8% 1.88 US$9,400
2024-05-29 2024-05-28 B Purchase
3.2
Williams Donald Allen
Non-Executive Director
1,000 +inf%
4.86
US$4,863 		1,000 +inf% 4.86 US$4,863
2024-05-28 2024-05-24 B Purchase
1.7
Finley John David

CEO, CFO, Director

Executive Director
1,000 +13.4%
4.81
US$4,810 		1,000 +13.4% 4.81 US$4,810
2024-02-07 2024-02-06 B Purchase
1.7
Finley John David

CEO, CFO, Director

Executive Director
10,000 +13.4%
0.47
US$4,692 		10,000 +13.4% 0.47 US$4,692
2024-02-01 2024-01-31 B Purchase
3.2
Williams Donald Allen
Non-Executive Director
10,000 +50.0%
0.61
US$6,050 		10,000 +50.0% 0.61 US$6,050
2024-02-01 2024-01-31 B Purchase
1.7
Finley John David

CEO, CFO, Director

Executive Director
10,000 +15.5%
0.56
US$5,590 		10,000 +15.5% 0.56 US$5,590
2023-09-29 2023-09-27 B Purchase
1.7
Finley John David

CEO, CFO, Director

Executive Director
15,000 +52.8%
0.54
US$8,088 		15,000 +52.8% 0.54 US$8,088
2023-09-29 2023-09-27 B Purchase
3.2
Williams Donald Allen
Non-Executive Director
20,000 +inf%
0.54
US$10,800 		20,000 +inf% 0.54 US$10,800
2023-09-15 2023-09-14 S Sale
1.1
Trenschel Robert J.
Non-Executive Director
300 -100.0%
0.64
US$192 		300 -100.0% 0.64 US$192
2023-09-14 2023-09-13 B Purchase
1.7
Finley John David

CEO, CFO, Director

Executive Director
15,000 +112.0%
0.66
US$9,825 		15,000 +112.0% 0.66 US$9,825
2022-09-02 2022-09-01 B Purchase
1.7
Finley John David

Chief Financial Officer

Officer
19,481 +15.1%
0.14
US$2,799 		19,481 +15.1% 0.14 US$2,799
2022-08-25 2022-08-23 B Purchase
1.7
Finley John David

Chief Financial Officer

Officer
7,350 +6.0%
0.16
US$1,176 		7,350 +6.0% 0.16 US$1,176
2022-08-18 2022-08-16 B Purchase
1.9
Hallam Thomas

Chief Executive Officer

Executive Director
40,000 +227.4%
0.25
US$10,000 		40,000 +227.4% 0.25 US$10,000
2022-08-18 2022-08-16 B Purchase
1.7
Finley John David

Chief Financial Officer

Officer
100,000 +456.7%
0.25
US$25,000 		100,000 +456.7% 0.25 US$25,000
2022-03-29 2022-03-28 B Purchase
1.9
Hallam Thomas

Chief Executive Officer

Executive Director
10,000 +131.7%
1.18
US$11,800 		10,000 +131.7% 1.18 US$11,800
2022-03-25 2022-03-24 B Purchase
1.7
Finley John David

Chief Financial Officer

Officer
7,500 +52.1%
1.09
US$8,174 		7,500 +52.1% 1.09 US$8,174
2021-09-13 2021-09-10 B Purchase
1.1
Trenschel Robert J.
Non-Executive Director
2,142 +16.7%
2.98
US$6,383 		2,142 +16.7% 2.98 US$6,383
2021-09-13 2021-09-09 B Purchase
1.1
Trenschel Robert J.
Non-Executive Director
3,400 +36.0%
2.89
US$9,826 		3,400 +36.0% 2.89 US$9,826
2021-09-13 2021-09-08 B Purchase
1.1
Trenschel Robert J.
Non-Executive Director
5,000 +112.2%
2.75
US$13,750 		5,000 +112.2% 2.75 US$13,750
2021-09-13 2021-09-07 B Purchase
1.1
Trenschel Robert J.
Non-Executive Director
2,707 +154.7%
2.78
US$7,525 		2,707 +154.7% 2.78 US$7,525
2021-09-13 2021-08-31 B Purchase
1.1
Trenschel Robert J.
Non-Executive Director
1,750 +inf%
2.75
US$4,812 		1,750 +inf% 2.75 US$4,812
2017-05-18 2017-05-17 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
7,500 +47.4%
4.00
US$30,000 		7,500 +47.4% 4.00 US$30,000
2017-03-27 2017-03-24 B Purchase LLOYD JONES JONATHAN BRIAN

Chief Financial Officer
5,455 +226.9%
5.50
US$30,002 		5,455 +226.9% 5.50 US$30,002
2017-02-27 2017-02-24 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
2,591 +19.6%
3.86
US$10,001 		2,591 +19.6% 3.86 US$10,001
2017-01-27 2017-01-25 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
2,841 +27.4%
3.52
US$10,000 		2,841 +27.4% 3.52 US$10,000
2016-12-30 2016-12-23 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
32,259 +31.4%
0.31
US$10,000 		32,259 +31.4% 0.31 US$10,000
2016-11-28 2016-11-25 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
35,715 +53.3%
0.28
US$10,000 		35,715 +53.3% 0.28 US$10,000
2016-10-27 2016-10-25 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
35,715 +114.3%
0.28
US$10,000 		35,715 +114.3% 0.28 US$10,000
2016-09-26 2016-09-23 B Purchase LLOYD JONES JONATHAN BRIAN

Chief Financial Officer

Officer
31,250 +inf%
0.32
US$10,000 		31,250 +inf% 0.32 US$10,000
2016-09-26 2016-09-23 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
31,250 +inf%
0.32
US$10,000 		31,250 +inf% 0.32 US$10,000
2015-11-16 2015-11-16 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.9%
1.09
US$27,250 		25,000 -2.9% 1.09 US$27,250
2015-11-09 2015-11-09 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.9%
1.18
US$29,500 		25,000 -2.9% 1.18 US$29,500
2015-11-03 2015-11-02 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.8%
1.17
US$29,355 		25,000 -2.8% 1.17 US$29,355
2015-10-27 2015-10-26 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.7%
1.13
US$28,190 		25,000 -2.7% 1.13 US$28,190
2015-10-19 2015-10-19 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.6%
1.23
US$30,690 		25,000 -2.6% 1.23 US$30,690
2015-10-13 2015-10-12 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.6%
1.31
US$32,725 		25,000 -2.6% 1.31 US$32,725
2015-10-05 2015-10-05 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.5%
1.26
US$31,460 		25,000 -2.5% 1.26 US$31,460
2015-09-28 2015-09-28 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.4%
1.64
US$41,000 		25,000 -2.4% 1.64 US$41,000
2015-09-21 2015-09-21 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.4%
1.52
US$38,078 		25,000 -2.4% 1.52 US$38,078
2014-09-03 2014-09-02 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.2%
4.09
US$24,540 		6,000 -1.2% 4.09 US$24,540
2014-08-04 2014-08-01 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.2%
2.78
US$16,680 		6,000 -1.2% 2.78 US$16,680
2014-07-01 2014-07-01 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.2%
4.17
US$25,020 		6,000 -1.2% 4.17 US$25,020
2014-06-02 2014-06-02 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.2%
4.25
US$25,500 		6,000 -1.2% 4.25 US$25,500
2014-05-07 2014-05-05 B Purchase OLDAKER WILLIAM CLYDE Non-Executive Director
985 +inf%
3.50
US$3,448 		985 +inf% 3.50 US$3,448
2014-05-07 2014-05-05 B Purchase OLDAKER WILLIAM CLYDE Non-Executive Director
14,250 +13.9%
3.50
US$49,874 		14,250 +13.9% 3.50 US$49,874
2014-05-05 2014-05-01 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.2%
3.54
US$21,255 		6,000 -1.2% 3.54 US$21,255
2014-04-23 2014-04-22 S Sale GARR RICHARD

CEO

Executive Director
7,000 -2.8%
4.25
US$29,750 		7,000 -2.8% 4.25 US$29,750
2014-04-02 2014-04-01 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.1%
4.11
US$24,638 		6,000 -1.1% 4.11 US$24,638
2014-03-21 2014-03-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.1%
4.04
US$24,249 		6,000 -1.1% 4.04 US$24,249
2013-11-07 2013-10-21 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
10,000 -1.4%
2.35
US$23,458 		10,000 -1.4% 2.35 US$23,458
2013-10-21 2013-10-18 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
10,000 -1.4%
2.44
US$24,446 		10,000 -1.4% 2.44 US$24,446
2013-09-23 2013-09-20 S Sale JOHE KARL

Chief Scientific Officer
10,000 -1.4%
2.62
US$26,241 		10,000 -1.4% 2.62 US$26,241
2013-09-19 2013-09-19 S Sale JOHE KARL

Chief Scientific Officer
10,000 -1.4%
2.61
US$26,094 		10,000 -1.4% 2.61 US$26,094
2013-08-21 2013-08-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
20,000 -2.7%
1.55
US$30,986 		20,000 -2.7% 1.55 US$30,986
2013-07-22 2013-07-22 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
12,800 -1.7%
1.62
US$20,780 		12,800 -1.7% 1.62 US$20,780
2013-06-21 2013-06-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
12,800 -1.7%
1.40
US$17,856 		12,800 -1.7% 1.40 US$17,856
2013-06-11 2013-06-07 S Sale GARR RICHARD

CEO

Executive Director
6,000 -2.8%
1.42
US$8,520 		6,000 -2.8% 1.42 US$8,520
2013-05-21 2013-05-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
12,800 -1.6%
1.51
US$19,301 		12,800 -1.6% 1.51 US$19,301
2013-04-23 2013-04-22 S Sale JOHE KARL

Chief Scientific Officer
12,800 -1.6%
1.13
US$14,520 		12,800 -1.6% 1.13 US$14,520
2013-03-22 2013-03-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
12,800 -1.6%
1.14
US$14,546 		12,800 -1.6% 1.14 US$14,546
2013-02-26 2013-02-25 S Sale GARR RICHARD

CEO

Executive Director
12,000 -5.3%
1.15
US$13,800 		12,000 -5.3% 1.15 US$13,800
2013-02-21 2013-02-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
12,800 -1.6%
1.18
US$15,104 		12,800 -1.6% 1.18 US$15,104
Explore more

More insider trading research around Palisade Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America